Effect of dronedarone on clinical end points in patients with atrial fibrillation and coronary heart disease: insights from the ATHENA trial

AIMS: This study aimed to assess safety and cardiovascular outcomes of dronedarone in patients with paroxysmal or persistent atrial fibrillation (AF) with coronary heart disease (CHD). Coronary heart disease is prevalent among AF patients and limits antiarrhythmic drug use because of their potential...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pisters, Ron, Hohnloser, Stefan H., Connolly, Stuart J., Torp-Pedersen, Christian, Naditch-Brûlé, Lisa, Page, Richard L., Crijns, Harry J.G.M.
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2014
Materias:
Clinical Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3905706/
https://ncbi.nlm.nih.gov/pubmed/24072451
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/europace/eut293
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares